It's not quite the Nostromo, but there's something very '70s sci-fi flick about the new Nvidia AI and healthcare supercomputer. It's called Cambridge-1, and it's a $100 million supercomputer built for scoping disease variations, designing drugs, and finding new treatments.
Take a look at these behind the scenes images.
If it's not the most stylish supercomputer you've ever seen (and please, show me another that oozes 2001: A Space Odyssey quite as much), it is as least the most powerful in ol' Albion. Cambridge-1 comes online as the UK's most powerful supercomputer, equipped with 80 golden DGX A100 systems.
- Turns out there's 'a big supercomputer at Nvidia… running 24/7, 365 days a year improving DLSS. And it's been doing that for six years'
- The world's fastest nuke-simulating supercomputer is now online, boasting peak performance of 2.79 quintillion calculations per second and other numbers my pea-sized brain can't comprehend
Each DGX system contains eight A100 GPUs, powered by the same Ampere architecture as the latest GeForce RTX 30-series cards, alongside NVSwitches, BlueField 2 DPUs, and AMD EPYC CPUs. In total, that amounts to 8 petaflops of Linpack supercomputer benchmark performance, and 400 petaflops of AI acceleration, Nvidia claims.
"Cambridge-1 will empower world-leading researchers in business and academia with the ability to perform their life’s work on the UK’s most powerful supercomputer, unlocking clues to disease and treatments at a scale and speed previously impossible in the UK," says Jensen Huang, Nvidia CEO. "The discoveries developed on Cambridge-1 will take shape in the UK, but the impact will be global, driving groundbreaking research that has the potential to benefit millions around the world."
Best gaming PC: the top pre-built machines from the pros
Best gaming laptop: perfect notebooks for mobile gaming
Cambridge-1's first jobs include work for AstraZeneca and GlaxoSmithKline on drug discovery, and King's College London and Guys' and St Thomas' NHS Foundation trust to teach AI models to generate synthetic brain models that can be used to enable earlier diagnosis and treatment of diseases, such as dementia, stroke, brain cancer, and multiple sclerosis.
Nvidia promised such a supercomputer as a part of its plan to buy up Cambridge-based chip designer, Arm. The deal has yet to be officially inked, however, and Nvidia is facing regulatory action in the UK due to national security concerns.
Cambridge-1 will, however, face stiff competition in the near future from the Met Office and Microsoft's advanced weather and climate supercomputer when it is finished summer of next year. That project is reportedly going to cost £1.2B ($1.6B) in total. The finished product will also be something special in that it will be powered entirely by renewable energy.
